full
border
#666666
http://www.lennonsearch.com/wp-content/themes/smartbox-installable/
https://www.lennonsearch.com/
#26ADE4
style3
Over 25 Years Of Expertise
828-403-6096

Archive for February, 2014

26
Feb

Life sciences venture outfit Abingworth is creeping up on a close for its 6th fund, according to Dow Jones Venturewire, reportedly outstripping its goal of $330 million as it stocks up for another round of investments. …read more Source: Report: Abingworth tees up $330M-plus to bankroll biotech bets     

26
Feb

Framingham, MA-based rEVO Biologics–formerly GTC Biotherapeutics–is planning to put its drug ATryn through a late-stage study for preeclampsia, looking to see if it can help women extend their pregnancy, helping the women as well as their newborns. …read more Source: REVO looks to expand use of Atryn with preeclampsia PhIII     

default
Loading posts...
link_magnifier
#5C5C5C
off
fadeInDown
loading
#5C5C5C
off